According to a study conducted by BSI, 54 percent of UK respondents expressed excitement about AI’s potential to revolutionise medical diagnoses and 43 percent welcomed AI’s role in reducing food waste. However, there is a prevailing lack of trust.

This scepticism could hinder the integration of AI technologies in the NHS, which is currently grappling with challenges like the COVID-19 backlog and an ageing population. Almost half of Britons (49%) support the use of AI to alleviate pressure on the healthcare system and reduce waiting times. However, only 20 percent have more confidence in AI than humans in detecting food contamination issues.

The study also highlighted a pressing need for education, as 65 percent of respondents felt patients should be informed about the use of AI tools in diagnosis or treatment. 37 percent of respondents expect to use AI regularly in medical settings by 2030.

Craig Civil, Director of Data Science and AI at BSI, said:

“The magnitude of ways AI can shape the UK’s future means we are seeing some degree of hesitation of the unknown. This can be addressed by developing greater understanding and recognition that human involvement will always be needed if we are to make the best use of this technology, and by ensuring we have frameworks that are in place to govern its use and build trust.

Now is the moment for the UK to collaborate to balance the great power of this tool with the realities of actually using it in a credible, authentic, well-executed, and well-governed way.

Closing the confidence gap and building the appropriate checks and balances can enable us to make not just good but great use of AI in every area of life and society.”

60 percent believed consumers needed protections regarding AI technologies. The study also revealed that 61 percent of Britons are calling for international guidelines to ensure the safe use of AI. This demand reflects a global sentiment, with 50 percent of respondents highlighting the need for ethical safeguards on patient data use.

Harold Pradal, Chief Commercial Officer at BSI, commented:

“AI is a transformational technology. For it to be a powerful force for good, trust needs to be the critical factor. There is a clear opportunity to harness AI to drive societal impact, change lives, and accelerate progress towards a better future and a sustainable world.

Closing the AI confidence gap is the first necessary step, it has to be delivered through education to help realise AI’s benefits and shape Society 5.0 in a positive way.”

The study’s findings are a call to action for the UK, urging collaboration and the establishment of frameworks to govern AI’s use.

The UK Government, recognising the importance of safe AI implementation, is set to host a global AI Safety Summit at the historic Bletchley Park on 1-2 November 2023. BSI is an official partner for the much-anticipated event.

(Photo by Suad Kamardeen on Unsplash)

See also: UK reveals AI Safety Summit opening day agenda

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is co-located with Digital Transformation Week.

Explore other upcoming enterprise technology events and webinars powered by TechForge here.

The post BSI: Closing ‘AI confidence gap’ key to unlocking benefits appeared first on AI News.

The guidance, titled ’Validation framework for the use of AI within healthcare – Specification (BS 30440),’ aims to bolster confidence among clinicians, healthcare professionals, and providers regarding the safe, effective, and ethical development of AI tools.

As the global debate on the appropriate use of AI continues, this auditable standard targets products primarily designed for healthcare interventions, diagnoses, and health condition management.

Jeanne Greathouse, Global Healthcare Director at BSI, said:

“This standard is highly relevant to organisations in the healthcare sector and those interacting with it. As AI becomes the norm, it has the potential to be transformative for healthcare.

With the onset of more innovative AI tools, and AI algorithms’ ability to digest and accurately analyse copious amounts of data, clinicians and health providers can efficiently make informed diagnostic decisions to intervene, prevent, and treat diseases, ultimately improving patients’ quality of life.”

According to forecasts, the global healthcare AI market is expected to surpass $187.95 billion by 2030. However, healthcare providers and clinicians may face challenges in assessing AI products due to time and budget constraints or a lack of in-house capabilities. 

The BS 30440 specification seeks to aid decision-making processes by providing criteria for evaluating healthcare AI products, including clinical benefit, performance standards, safe integration into clinical environments, ethical considerations, and equitable social outcomes.

The standard covers a wide range of healthcare AI products, including regulated medical devices like software used for medical purposes, imaging software, patient-facing products like AI-powered smartphone chatbots, and home monitoring devices. It applies to products and technologies utilising AI elements – including machine learning – and is relevant to both AI system suppliers and product auditors.

The development of this specification involved collaboration among a panel of experts, including clinicians, software engineers, AI specialists, ethicists, and healthcare leaders. The guidance draws from existing literature and best practices, translating complex functionality assessments into an auditable framework for AI system conformity.

Healthcare organisations will be able to mandate BS 30440 certification in their procurement processes to ensure adherence to these recognized standards.

Scott Steedman, Director General for Standards at BSI, commented:

“The new guidance can help build digital trust in cutting-edge tools that represent enormous potential benefit to patients, and the professionals diagnosing and treating them.

AI has the potential to shape our future in a positive way and we all need confidence in the tools being developed, especially in healthcare.

This specification, which is auditable, can help guide everyone from doctors to healthcare leaders and patients to choose AI products that are safe, effective, and ethically produced.”

The specification addresses the need for an agreed validation framework for AI development and clinical evaluation in healthcare. It builds on a framework initially piloted at Guy’s and St. Thomas Cancer Centre and later revised through discussions with stakeholders involved in AI and machine learning.

With the publication of this guidance, BSI seeks to instil confidence in AI products used in healthcare and empower doctors, healthcare leaders, and patients to make informed and ethical choices for improved patient care and overall societal benefit.

As AI continues to shape the future of healthcare, adherence to recognised standards will play a vital role in ensuring the safe and effective integration of AI technologies in medical practice.

(Photo by Owen Beard on Unsplash)

See also: AI regulation: A pro-innovation approach – EU vs UK

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The event is co-located with Digital Transformation Week.

Explore other upcoming enterprise technology events and webinars powered by TechForge here.

The post BSI publishes guidance to boost trust in AI for healthcare appeared first on AI News.